Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00311688 · ClinicalTrials.gov registry record
Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
NCT00311688: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00311688 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00311688 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
Study Summary
Interleukin-2 (IL-2) is a protein found naturally in the blood that helps boost the immune system. The purpose of this study is to provide long-term treatment and monitoring of HIV infected people enrolled in NIAID-funded studies investigating the use of laboratory-made IL-2 for the treatment of HIV infection.
Interventions
- DRUG Interleukin-2
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-12 |
| Est. Completion | 2008-12 |
What the finished NCT00311688 record still lists
NCT00311688 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Interleukin-2 is the first listed.
NCT00311688 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00311688 about?
NCT00311688 is a clinical study titled "Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies". Interleukin-2 (IL-2) is a protein found naturally in the blood that helps boost the immune system. The purpose of this study is to provide long-term treatment and monitoring of HIV infected people enrolled in NIAID-funded studies investigating the use of laboratory-made IL-2 for the treatment of HIV...
What is the current status of trial NCT00311688?
This trial is currently completed. The study started on 2003-12. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00311688?
The interventions under investigation include: Interleukin-2 (DRUG).
Who is sponsoring clinical trial NCT00311688?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia